The FTSE 100 lost ground today, down 5.31 points at 7,032.70 just before markets closed after a turbulent start [...]

Shares in Astrazeneca dipped after the pharmaceutical giant revealed it had not reached the results it had hoped [...]

Back in July 2016, Theresa May launched her campaign for leadership of the Conservative party by promising radical [...]

The boards at several big-name companies will face a barrage of investor questions this week, as shareholders [...]

British Gas owner Centrica said in a trading update today that its services division had been under pressure due [...]

Major UK firms have told ministers of their fears that Brexit could leave them facing a shortfall of workers. [...]

Those looking for an income from the stock market often turn to Equity Income funds. They provide a portfolio [...]

Astrazeneca has hailed the success of its new Type 2 diabetes drugs, after a study of more than 300,000 people [...]

Shares in Neil Woodford-backed pharmaceuticals firm Circassia rocketed over 30 per cent this morning after [...]

Pharmaceuticals giant AstraZeneca has turned to an innovative startup helping patients, doctors and researchers [...]

AstraZeneca has struck a $320m (£256m) deal with TerSera Therapeutics to sell the commercial rights of its [...]

AstraZeneca shares slipped over one per cent after warning many of its patents will run out during 2017. [...]

AstraZeneca is forecast to report disappointing results this week as competition continues to drag on sales. [...]

London's top share index hit a fresh all-time high yesterday, setting a record for the longest winning streak [...]

2016's events made fools of most pundits, and looking back at my column exactly a year ago, I fared little better. [...]